Login / Signup

Assessing the Value of Incorporating a Polygenic Risk Score with Nongenetic Factors for Predicting Breast Cancer Diagnosis in the UK Biobank.

Jennifer A CollisterXiaonan LiuThomas J LittlejohnsJack M CuzickLei CliftonDavid J Hunter
Published in: Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology (2024)
These findings could have important implications for the ongoing discussion about the value of PRS in risk prediction models and screening.
Keyphrases
  • cross sectional